Fintel reports that on July 14, 2025, BTIG downgraded their outlook for TechnipFMC (NYSE:FTI) from Buy to Neutral. Analyst ...

Fintel reports that on July 14, 2025, BTIG upgraded their outlook for Ally Financial (NYSE:ALLY) from Sell to Neutral.

Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat ...

I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision ...

BTIG downgraded AFRM to "neutral" from "buy" Though shares of buy-now-pay-later name Affirm Holdings Inc (NASDAQ:AFRM) have ...

As of Monday, the S&P 500 has been trading above its 20-day moving average for 55 days. That's the longest stretch since ...

Billionaire Kerr Neilson has bought over $8 million worth of shares in Flutter Entertainment plc (NYSE:FLUT), representing ...

Novavax Inc. (NASDAQ:NVAX) is one of the best cheap stocks with huge upside potential. On June 11, BTIG maintained a Buy ...

BTIG’s Tim Chiang believes the company is steadily progressing with these key programs. The analyst said, “We believe SRPT is making progress on the gene therapy manufacturing front, ...

BTIG made the claim in a lawsuit filed late Monday in California state court and seeks at least $200 million in damages. Have a confidential tip for our reporters? Get in Touch.

NEW YORK--(BUSINESS WIRE)--BTIG announced today that the firm will be hosting a monthly fireside chat series focused on blockchain and cryptocurrency-related companies.Each month, a senior ...

Noted BTIG analysts Walter Piecyk and Brandon Ross will join Greenfield in what BTIG co-founder Steven Starker introduced on Thursday as “a new media company that is expected to fully assess ...